mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |